A review of contemporary options for medical management of hemangiomas, other vascular tumors, and vascular malformations

Pharmacology and Therapeutics

Volumn 139, Issue 3, 2013, Pages 327-333

  Blatt, Julie ^a,b   McLean, Thomas W ^c   Castellino, Sharon M ^c   Burkhart, Craig N ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Drug treatment; Hemangioma; Vascular anomaly; Vascular malformation

Indexed keywords

ACEBUTOLOL; ALPHA INTERFERON; ATENOLOL; BEVACIZUMAB; CAPTOPRIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXYCYCLINE; GAMMA INTERFERON; IMIQUIMOD; INFLIXIMAB; LENALIDOMIDE; MARIMASTAT; MINOCYCLINE; NADOLOL; OCTREOTIDE; PAZOPANIB; PIMECROLIMUS; PLACEBO; PREDNISONE; PROPRANOLOL; PSEUDOMONIC ACID; RAPAMYCIN; SEMAXANIB; SUNITINIB; TACROLIMUS; THALIDOMIDE; TIMOLOL MALEATE; UNINDEXED DRUG; VINCRISTINE;

ALLERGIC REACTION; ALOPECIA; ANGIODYSPLASIA; ARTERIOVENOUS MALFORMATION; BLEEDING; BLUE RUBBER BLEB NEVUS; BRADYCARDIA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CAPILLARY HEMANGIOMA; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CONGENITAL BLOOD VESSEL MALFORMATION; CORTICOSTEROID THERAPY; CYTOPENIA; DIARRHEA; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; GASTROINTESTINAL SYMPTOM; HAMARTOMA; HEADACHE; HEMANGIOBLASTOMA; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HEMANGIOMATOSIS; HUMAN; HYPERKALEMIA; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; HYPOGLYCEMIA; HYPOTENSION; IRON THERAPY; LOW LEVEL LASER THERAPY; LYMPHANGIOMATOSIS; MULTIMODALITY CANCER THERAPY; NEVUS FLAMMEUS; PARESTHESIA; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PULSED DYE LASER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RESPIRATORY DISTRESS; REVIEW; SCLEROTHERAPY; SOMNOLENCE; STURGE WEBER SYNDROME; THROMBOEMBOLISM; THROMBOSIS; TOOTH DISCOLORATION; TREATMENT INDICATION; TREATMENT RESPONSE; VASCULAR TUMOR;

<5 CASES DEMONSTRATING EFFICACY; ARTERIOVENOUS MALFORMATION; AVM; C; CAPILLARY MALFORMATION; CCM; CEREBRAL CAVERNOUS MALFORMATION; CM; DRUG TREATMENT; FGF; FIBROBLAST GROWTH FACTOR; HEMANGIOMA; HEMANGIOMA OF INFANCY; HEREDITARY HEMORRHAGIC TELANGIECTASIA; HHT; IH; KASABACH-MERRITT SYNDROME; KMS; LM; LYMPHATIC MALFORMATION; MAMMALIAN TARGET OF RAPAMYCIN; MATRIX METALLOPROTEINASE; MMP; MTOR; R; RANDOMIZED CLINICAL TRIAL; RETROSPECTIVE SERIES≥5 CASES DEMONSTRATING EFFICACY; RS; S; SINGLE ARM CLINICAL TRIAL; VASCULAR ANOMALY; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR MALFORMATION; VEGF; VENOUS MALFORMATION; VM;

CLINICAL TRIALS AS TOPIC; DRUG DESIGN; HEMANGIOMA; HUMANS; MOLECULAR TARGETED THERAPY; VASCULAR MALFORMATIONS; VASCULAR NEOPLASMS;

EID: 84881259090     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.05.001     Document Type: Review

References (71)

1. Z. Adam, L. Pour, M. Krejcí, E. Pourová, O. Synek, and L. Zahradová Successful treatment of angiomatosis with thalidomide and interferon alpha. A description of five cases and overview of treatment of angiomatosis and proliferating hemangiomas Vnitr Lek 56 2010 810 823
2. D. Aguilera, T. Tomita, S. Goldman, and J. Fangusaro Incidental resolution of a radiation-induced cavernous hemangioma of the brain following the use of bevacizumab in a child with recurrent medulloblastoma Pediatr Neurosurg 46 2010 303 307
3. M. Agulnik, J.L. Yarber, S.H. Okuno, M. von Mehren, B.D. Jovanovic, and B.E. Brockstein An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas Ann Oncol 24 2013 257 263
4. V. Albiñana, M.E. Bernabeu-Herrero, R. Zarrabeitia, C. Bernabéu, and L.M. Botella Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): effects of raloxifene on Endoglin and ALK1 expression in endothelial cells Thromb Haemost 103 2010 525 534
5. V. Albiñana, L. Recio-Poveda, R. Zarrabeitia, C. Bernabéu, and L.M. Botella Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia Thromb Haemost 108 2012 41 53
6. A. Amanzada, G.J. Töppler, S. Cameron, H. Schwörer, and G. RamadorI A case report of a patient with hereditary hemorrhagic telangiectasia treated successively with thalidomide and bevacizumab Case Rep Oncol 3 2010 463 470
7. M. Annabel, B. Shanna, L. Gerard, P.L. Soizick, H. Denis, and E. Allan Lack of effect of propranolol in the treatment of lymphangioma in two children Pediatr Dermatol 2012, Sept 25 10.1111/j.1525-1470.2012.01864.x (Epub ahead of print)
8. C. Badger, N. Preston, K. Seers, and P. Mortimer Benzo-pyrones for reducing and controlling lymphoedema of the limbs Cochrane Database Syst Rev 2 2004 CD003140
9. R.B. Barry, B.R. Hughes, and L.J. Cook Involution of infantile haemangiomas after imiquimod 5% cream Clin Exp Dermatol 33 2008 446 449 (Pubitemid 351832123)
10. A.A. Beigi, A.M. Sadeghi, H. Masoudpour, S. Shirazinejad, and P. Mottaghi Intravenous pamidronate for refractory lymphedema Iran Red Crescent Med J 13 2011 263 266
11. C. Blanchet, R. Nicollas, M. Bigorre, P. Amedro, and M. Mondain Management of infantile subglottic hemangioma: acebutolol or propranolol? Int J Pediatr Otorhinolaryngol 74 2010 959 961
12. J. Blatt, J. Stavas, B. Moats-Staats, J. Woosley, and D.S. Morrell Treatment of childhood kaposiform hemangioendothelioma with sirolimus Pediatr Blood Cancer 55 2010 1396 1398
13. J. Blatt, D. Morrell, S. Buck, C. Zdanski, S. Gold, and J. Stavas Beta blockers for infantile hemangiomas: a single institution experience Clin Pediatr 50 2011 757 763
14. F. Blei Peripheral vascular anomalies, malformations, and vascular tumors M.A. Creager, J.A. Beckman, J. Loscalzo, Vascular Medicine: A Companion to Braunwald's Heart Disease 2nd ed. 2013 Elsevier Philadelphia 790 809
15. S.J. Bowcock, and H.E. Patrick Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias? Br J Haematol 146 2009 220 222
16. C. Brown, V. Subramanian, C.M. Wilcox, and S. Peter Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies Dig Dis Sci 55 2010 2129 2134
17. L.M. Buckmiller Update on hemangiomas and vascular malformations Curr Opin Otolaryngol Head Neck Surg 12 2004 476 487 (Pubitemid 39565201)
18. P.E. Burrows, J.B. Mulliken, S.J. Fishman, G.L. Klement, and J. Folkman Pharmacological treatment of a diffuse arteriovenous malformation of the upper extremity in a child J Craniofac Surg 20 Suppl. 1 2009 597 602
19. J.F. Capitanio, E. Mazza, M. Motta, and M. Reni Mechanisms, indications and results of salvage systemic therapy for sporadic and von Hippel-Lindau related hemangioblastomas of the central nervous system Crit Rev Oncol Hematol 86 2013 6 84
20. Y.E. Chiu, B.A. Drolet, F. BleI, M. Carcao, J. Fangusaro, and M.E. Kelly Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon Pediatr Blood Cancer 59 2012 934 938
21. I. Choi, S. Lee, H. Kyoung Chung, Y. Suk Lee, K. Eui Kim, and D. Choi 9-Cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema Circulation 125 2012 872 882
22. R.J. D'Amato, M.S. Loughnan, E. Flynn, and J. Folkman Thalidomide is an inhibitor of angiogenesis Proc Natl Acad Sci USA 91 1994 4082 4085 (Pubitemid 24139577)
23. B.A. Drolet, P.C. Frommelt, S.L. Chamlin, A. Haggstrom, N.M. Bauman, and Y.E. Chiu Initiation and use of propranolol for infantile hemangioma: report of a consensus conference Pediatrics 131 2013 128 140
24. S. Dupuis-Girod, I. Ginon, J.C. Saurin, D. Marion, E. Guillot, and E. Decullier Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output JAMA 307 2012 948 955
25. O. Enjolras, and J.B. Mulliken Vascular tumors and vascular malformations (new issues) Adv Dermatol 13 1997 375 423
26. M. Franchini, F. Frattini, S. Crestani, and C. Bonfanti Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide J Thromb Thrombolysis 2013 (in press, Electronic publication ahead of print)
27. T. Frenzel, C.Z. Lee, H. Kim, N.J. Quinnine, T. Hashimoto, and M.T. Lawton Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance Cerebrovasc Dis 25 2008 157 163 (Pubitemid 351280391)
28. Z.Z. Ge, H.M. Chen, Y.J. Gao, W.Z. Liu, C.H. Xu, and H.H. Tan Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation Gastroenterology 141 2011 1629 1637
29. S. Gottschling, G. Schneider, S. Meyer, H. Reinhard, D. Dill-Mueller, and N. Graf Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide Pediatr Blood Cancer 46 2006 239 242 (Pubitemid 43076076)
30. S. Greenberger, and J. Bischoff Infantile hemangioma - mechanism(s) of drug action on a vascular tumor Cold Spring Harb Perspect Med 1 2011 a006460
31. S. Greenberger, S. Yuan, L.A. Walsh, E. Boscolo, K.T. Kang, and B. Matthews Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma J Invest Dermatol 131 2011 2467 2476
32. T. Grenader, F. Vernea, C. Reinus, and A. Gabizon Malignant epithelioid hemangioendothelioma of the liver successfully treated with pegylated liposomal doxorubicin J Clin Oncol 29 2011 e722 e724
33. A.M. Hammill, M. Wentzel, A. Gupta, S. Nelson, A. Lucky, and R. Elluru Sirolimus for the treatment of complicated vascular anomalies in children Pediatr Blood Cancer 57 2011 1018 1024
34. L.A. Hassell, and D. Roanh le Potential response to curcumin in infantile hemangioendothelioma of the liver Pediatr Blood Cancer 55 2010 377 379
35. M. Hochman, D.M. Adams, and T.D. Reeves Current knowledge and management of vascular anomalies, II: malformations Arch Facial Plast Surg 13 2011 425 433
36. M. Hogeling, S. Adams, and O. Wargon A randomized controlled trial of propranolol for infantile hemangiomas Pediatrics 128 2011 e259 e266
37. I. Iacobas, P.E. Burrows, D.M. Adams, V.R. Sutton, L.H. Hollier, and M.M. Chintagumpala Oral rapamycin in the treatment of patients with hamartoma syndromes and PTEN mutation Pediatr Blood Cancer 57 2011 321 323
38. T.T. Karnezis, and T.M. Davidson Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy Laryngoscope 122 2012 495 497
39. B.Y. Kim, E. Jonasch, and I.E. McCutcheon Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report Target Oncol 7 2012 145 149
40. D.J. Kouba, D. Yip, E.F. Fincher, and R.L. Moy Topical imiquimod in the treatment of a long-standing capillary malformation Br J Dermatol 157 2007 1071 1072 (Pubitemid 47583528)
41. A.M. Kulungowski, A.H. Hassanein, V. Nosé, S.J. Fishman, J.B. Mulliken, and J. Upton Expression of androgen, estrogen, progesterone, and growth hormone receptors in vascular malformations Plast Reconstr Surg 129 2012 919e 924e
42. E. Lazaridou, C. Giannopoulou, Z. Apalla, C. Fotiadou, C. Tsorova, and D. Ioannides Calcineurin inhibitors in the treatment of cutaneous infantile haemangiomas J Eur Acad Dermatol Venereol 24 2010 614 615
43. C. Leaute-Labreze, E. Dumas de la Roque, T. Hubiche, F. Boralevi, J.B. Thambo, and A. Taïeb Propranolol for severe hemangiomas of infancy N Engl J Med 358 2008 2649 2651 (Pubitemid 351831393)
44. F. Lebrin, S. Srun, K. Raymond, S. Martin, S. van den Brink, and C. Freitas Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia Nat Med 16 2010 420 428
45. W. Liu, S. Zhang, T. Hu, X. Jiang, X. Hu, and J. Feng Sex hormone receptor of hemangioma and vascular malformation in children Zhonghua Wai Ke Za Zhi 37 1999 295 297
46. D.J. Marsh, T.N. Trahair, J.L. Martin, W.Y. Chee, J. Walker, and E.P. Kirk Rapamycin treatment for a child with germline PTEN mutation Nat Clin Pract 5 2008 357 361 (Pubitemid 351780952)
47. E.F. Mathes, A.N. Haggstrom, C. Dowd, W.Y. Hoffman, and I.J. Frieden Clinical characteristics and management of vascular anomalies: findings of a multidisciplinary vascular anomalies clinic Arch Dermatol 140 2004 979 983 (Pubitemid 39062649)
48. N. Miyake, H. Chikumi, M. Takata, M. Nakamoto, T. Igishi, and E. Shimizu Rapamycin induces p53-independent apoptosis through the mitochondrial pathway in non-small cell lung cancer cells Oncol Rep 28 2012 848 854
49. M. Moschovi, G.A. Alexiou, K. Stefanaki, N. Tourkantoni, and N. Prodromou Propranolol treatment for a giant infantile brain cavernoma J Child Neurol 25 2010 653 655
50. H.B. Moss, D.T. Sines, J. Blatt, J.J. Dutton, and A.D. Proia Epithelioid hemangioma responsive to oral propranolol Ophthal Plast Reconstr Surg 28 2012 e88 e90
51. B.A. Nacev, P. Grassi, A. Dell, S.M. Haslam, and J.O. Liu The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells J Biol Chem 286 2011 44045 44056
52. J.S. Nelson, W. Jia, T.L. Phung, and M.C. Mihm Jr. Observations on enhanced port wine stain blanching induced by combined pulsed dye laser and rapamycin administration Lasers Surg Med 43 2011 939 942
53. K. Ogawa-Ochiai, N. Sekiya, Y. Kasahara, A. Chino, K. Ueda, and Y. Kimata A case of mediastinal lymphangioma successfully treated with Kampo medicine J Altern Complement Med 17 2011 563 565
54. K. Ogura, Y. Shinoda, T. Okuma, T. Ushiku, T. Motoi, and H. Kawano Recurrent epithelioid hemangioma: therapeutic potential of tranilast and indomethacin J Orthop Sci 17 2012 194 198
55. M. OzekI, T. Fukao, and N. Kondo Propranolol for intractable diffuse lymphangiomatosis N Engl J Med 364 2011 1380 1382
56. A. Papa, C. Felice, M. Marzo, and L. Guidi A case of hereditary hemorrhagic telangiectasia associated with Crohn's disease successfully treated with infliximab Am J Gastroenterol 105 2010 1904
57. J. Pintoffl, I. Meisinger, F. Mayer, M. Horger, C. von Weyhern, and L. Kanz Long-term disease stabilization during second-line gemcitabine in a refractory metastatic haemangioendothelioma Anticancer Drugs 20 2009 73 74
58. E. Pope, and A. Chakkittakandiyii Topical timolol gel for infantile hemangiomas: a pilot study Arch Dermatol 146 2010 564 565
59. E. Pope, A. Chakkittakandiyil, I. Lara-Corrales, E. Maki, and M. Weinstein Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol Br J Dermatol 168 2013 222 224
60. M.F. Raphaël, M. de Graaf, C.C. Breugem, S.G. Pasmans, and J.M. Breur Atenolol: a promising alternative to propranolol for the treatment of hemangiomas J Am Acad Dermatol 65 2011 420 421
61. J. Reinglas, R. Ramphal, and M. Bromwich The successful management of diffuse lymphangiomatosis using sirolimus: a case report Laryngoscope 121 2011 1851 1854
62. C. Riklin, K. Seystahl, S. Hofer, C. Happold, R. Winterhalder, and M. Weller Antiangiogenic treatment for multiple CNS hemangioblastomas Onkologie 35 2012 443 445
63. F. Salech, S. Valderrama, B. Nervi, J.C. Rodriguez, D. Oksenberg, and A. Koch Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up Ann Hepatol 10 2011 99 102
64. I. Sanchez-Carpintero, M.I. Martínez, and M.C. Mihm Jr. Clinical and histopathologic observations of the action of imiquimod in an epithelioid hemangioendothelioma and Paget's mammary disease J Am Acad Dermatol 55 2006 75 79 (Pubitemid 43867036)
65. N. Shoeibi, H. Ahmadieh, M. Abrishami, and H. Poorzand Rapid and sustained resolution of serous retinal detachment in Sturge-Weber syndrome after single injection of intravitreal bevacizumab Ocul Immunol Inflamm 19 2011 358 360
66. A. Sumrall, R. Fredericks, A. Berthold, and G. Shumaker Lenalidomide stops progression of multifocal epithelioid hemangioendothelioma including intracranial disease J Neurooncol 97 2010 275 277
67. G.L. Swetman, D.R. Berk, S.S. Vasanawala, J.A. Feinstein, A.T. Lane, and A.L. Bruckner Sildenafil for severe lymphatic malformations N Engl J Med 366 2012 384 386
68. S.T. Tan, T. Itinteang, D.J. Day, C. O'Donnell, J.A. Mathy, and P. Leadbitter Treatment of infantile haemangioma with captopril Br J Dermatol 167 2012 619 624
69. E. van Cutsem, P. Rutgeerts, and G. Vantrappen Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone Lancet 335 1990 953 955 (Pubitemid 20134976)
70. E. Yaniv, M. Preis, T. Hadar, J. Shvero, and M. Haddad Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial Laryngoscope 119 2009 284 288
71. H. Yuksekkaya, O. Ozbek, M. Keser, and H. Toy Blue rubber bleb nevus syndrome: successful treatment with sirolimus Pediatrics 129 2012 e1080 e1084